Clinical results of intermittent endocrine treatment in low-volume prostate cancer patients

被引：0
|
作者：
Tunn, UW
机构：
来源：
RECENT ADVANCES IN PROSTATE CANCER AND BPH | 1997年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：121 / 125
页数：5
相关论文
共 50 条
  • [21] Further Support for Active Surveillance in the Management of Low-Volume, Low-Grade Prostate Cancer
    Albertsen, Peter
    EUROPEAN UROLOGY, 2010, 58 (06) : 836 - 837
  • [22] Treatment of lipedema by low-volume micro-cannular liposuction in tumescent anesthesia: Results in 111 patients
    Wollina, Uwe
    Heinig, Birgit
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [23] Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer
    Shaw, G.
    Oliver, R. T. D.
    SURGICAL ONCOLOGY-OXFORD, 2009, 18 (03): : 275 - 282
  • [24] Socioeconomic and Racial Differences in Treatment for Breast Cancer at a Low-Volume Hospital
    Amanda L. Kong
    Tina W. F. Yen
    Liliana E. Pezzin
    Haiyan Miao
    Rodney A. Sparapani
    Purushottam W. Laud
    Ann B. Nattinger
    Annals of Surgical Oncology, 2011, 18 : 3220 - 3227
  • [25] Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
    Tergast, Tammo L.
    Griemsmann, Marie
    Stockhoff, Lena
    Port, Kerstin
    Heidrich, Benjamin
    Cornberg, Markus
    Wedemeyer, Heiner
    Lenzen, Henrike
    Richter, Nicolas
    Jaeckel, Elmar
    Maasoumy, Benjamin
    JAMA NETWORK OPEN, 2023, 6 (07) : E2322048
  • [26] Socioeconomic and Racial Differences in Treatment for Breast Cancer at a Low-Volume Hospital
    Kong, Amanda L.
    Yen, Tina W. F.
    Pezzin, Liliana E.
    Miao, Haiyan
    Sparapani, Rodney A.
    Laud, Purushottam W.
    Nattinger, Ann B.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (11) : 3220 - 3227
  • [27] Intermittent androgen suppression as treatment for patients with prostate cancer
    Theyer, G
    Hamilton, G
    AKTUELLE UROLOGIE, 1998, 29 (01) : 6 - 12
  • [28] Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer Reply
    Patel, Hiten D.
    Tosoian, Jeffrey J.
    Carter, H. Ballentine
    Epstein, Jonathan I.
    JAMA ONCOLOGY, 2018, 4 (08) : 1133 - 1134
  • [29] Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    Lin, Yen-Chi
    Lin, Po-Hung
    Shao, I-Hung
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Liu, Chung-Yi
    Yu, Kai-Jie
    Chang, Ying-Hsu
    Pang, See-Tong
    Huang, Jhen-Ling
    Chuang, Cheng-Keng
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [30] CLINICAL REVIEW 37 - ENDOCRINE TREATMENT OF PROSTATE-CANCER
    SANTEN, RJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (03): : 685 - 689
12345